Illumina, Inc. - Common Stock (ILMN) stock analysis
ILMN · Illumina, Inc. - Common Stock
Latest recorded price: USD 198.00
Model-estimated fair value: USD 18.43. This assumption-based estimate is for general research and is not investment advice.
Sector and industry: Healthcare · Diagnostics & Research
At $198.00, ILMN trades 974.4% above the model's base-case value of $18.43. Using FCFF DCF, the model estimates $15.12 in the conservative case and $25.14 in the optimistic case, with a valuation confidence score of 55/100. Fiscal 2025 figures: revenue growth -1.8%, free cash flow margin 21.4%, ROIC 20.1%. The model flags 1 risk signal for this company (1 high severity).